Steepness of the radiation dose-response curve for dose-per-fraction escalation keeping the number of fractions fixed

References

• Bentzen SM. Radiobiological considerations in the design of clinical trials. Radiother Oncol 1994; 32: 1–11
   PubMed Web of Science ®Google Scholar
• Brahme A. Dosimetric precision requirements in radiation therapy. Acta Radiol Oncol 1984; 23: 379–91
   PubMed Web of Science ®Google Scholar
• Bentzen SM, Tucker SL. Quantifying the position and steepness of radiation dose-response curves [see comments]. Int J Radiat Biol 1997; 71(5)531–42
   PubMed Web of Science ®Google Scholar
• Mehta M, Scrimger R, Mackie R, Paliwal B, Chappell R, Fowler J. A new approach to dose escalation in non-small-cell lung cancer. Int J Radiat Oncol Biol Phys 2001; 49(1)23–33
   PubMed Web of Science ®Google Scholar
• Yarnold J, Ashton A, Bliss J, Homewood J, Harper C, Hanson J, et al. Fractionation sensitivity and dose response of late adverse effects in the breast after radiotherapy for early breast cancer: long-term results of a randomised trial. Radiother Oncol 2005; 75(1)9–17
   PubMed Web of Science ®Google Scholar
• Bentzen SM, Ritter MA The alpha/beta ratio for prostate cancer: What is it, really? Radiother Oncol 2005;76(1):1–3.
   PubMed Web of Science ®Google Scholar
• Fowler JF, Ritter MA, Chappell RJ, Brenner DJ. What hypofractionated protocols should be tested for prostate cancer?. Int J Radiat Oncol Biol Phys 2003; 56(4)1093–104
   PubMed Web of Science ®Google Scholar
• Brenner DJ, Hall EJ. Fractionation and protraction for radiotherapy of prostate carcinoma. Int J Radiat Oncol Biol Phys 1999; 43(5)1095–101
   PubMed Web of Science ®Google Scholar
• Owen J, Ashton A, Regan J, Broad B, Jackson C, Homewood J, et al. Fractionation sensitivity of breast cancer. Results of a randomised trial. European Journal of Cancer Supplements 2003; 1(5)S9
   Google Scholar
• Bentzen SM, Overgaard J, Thames HD, Overgaard M, Hansen PV, von der Maase H, et al. Clinical radiobiology of malignant melanoma. Radiother Oncol 1989; 16: 169–82
   PubMed Web of Science ®Google Scholar
• Lauve A, Morris M, Schmidt-Ullrich R, Wu Q, Mohan R, Abayomi O, et al. Simultaneous integrated boost intensity-modulated radiotherapy for locally advanced head-and-neck squamous cell carcinomas: II–clinical results. Int J Radiat Oncol Biol Phys 2004; 60(2)374–87
   PubMed Web of Science ®Google Scholar
• Fogliata A, Bolsi A, Cozzi L, Bernier J. Comparative dosimetric evaluation of the simultaneous integrated boost with photon intensity modulation in head and neck cancer patients. Radiother Oncol 2003; 69(3)267–75
   PubMed Web of Science ®Google Scholar
• Mohan R, Wu Q, Manning M, Schmidt-Ullrich R. Radiobiological considerations in the design of fractionation strategies for intensity-modulated radiation therapy of head and neck cancers. Int J Radiat Oncol Biol Phys 2000; 46(3)619–30
   PubMed Web of Science ®Google Scholar
• Withers HR. Biologic basis of radiation therapy. Principles and practice of radiation oncology, CA Perez, LW Brady. J.B.Lippincott Company, Philadelphia 1992; 64–96
   Google Scholar
• Agren-Cronqvist A, Källman P, Turesson I, Brahme A. Volume and heterogeneity dependence of the dose-response relationship for head and neck tumours. Acta Oncol 1995; 34: 851–60
   PubMedGoogle Scholar
• Bentzen SM, Overgaard J. Clinical normal-tissue radiobiology. In: Tobias JS, Thomas PRM, editors. Current radiation oncology. London: Arnold 1996; 2: 37–67
   Google Scholar
• Khalil AA, Bentzen SM, Overgaard J. Steepness of the dose-response curve as a function of volume in an experimental tumor irradiated under ambient or hypoxic conditions [see comments]. Int J Radiat Oncol Biol Phys 1997; 39(4)797–802
   PubMed Web of Science ®Google Scholar
• Withers HR, Thames HD, Peters LJ. A new isoeffect curve for change in dose per fraction. Radiother Oncol 1983; 1: 187–91
   PubMedGoogle Scholar
• Turesson I. Dose-response relationships for late effects on skin and mucosa. Acute and long-term side-effects of radiotherapy, W Hinkelbein, G Bruggmoser, H Frommhold, M Wannenmacher. Springer-Verlag, Berlin 1993; 49–57
   Google Scholar
• Turesson I, Thames HD. Repair capacity and kinetics of human skin during fractionated radiotherapy: Erythema, desquamation, and telangiectasia after 3 and 5 year's follow-up. Radiother Oncol 1989; 15: 169–88
   PubMed Web of Science ®Google Scholar
• Bentzen SM, Turesson I, Thames HD. Fractionation sensitivity and latency of telangiectasia after postmastectomy radiotherapy. A graded response analysis. Radiother Oncol 1990; 18: 95–106
   PubMed Web of Science ®Google Scholar
• Bentzen SM. High-tech in radiation oncology: Should there be a ceiling?. Int J Radiat Oncol Biol Phys 2004; 58(2)320–30
   PubMed Web of Science ®Google Scholar
• Lind BK, Nilsson J, Lof J, Brahme A. Generalization of the normalized dose-response gradient to non-uniform dose delivery. Acta Oncol 2001; 40(6)718–24
   PubMed Web of Science ®Google Scholar
• Tucker SL, Dong L, Cheung R, Johnson J, Mohan R, Huang EH, et al. Comparison of rectal dose-wall histogram versus dose-volume histogram for modeling the incidence of late rectal bleeding after radiotherapy. Int J Radiat Oncol Biol Phys 2004; 60(5)1589–601
   PubMed Web of Science ®Google Scholar
• Bentzen SM, Skoczylas JZ, Bernier J. Quantitative clinical radiobiology of early and late lung reactions. Int J Radiat Biol 2000; 76(4)453–62
   PubMed Web of Science ®Google Scholar